Genzyme Corporate Research Search Genzyme Websites
Information for Fabry Disease patients and their familiesFabry disease treatment information for health care professionals
Fabrazyme This website is intended for use in the United States. Please visit the Genzyme website for your country or region.
Health Care Professionals
About Fabry Disease
About Fabrazyme
Treatment
Support and Resources
Insurance
Fabry Publications
Information Request
Ask Us
Diagnostic Testing
Fabry Registry
Research and Development
Clinical Trials
Prescribing Information
Genzyme Fabrazyme

Fabry Registry

The Fabry Registry, a Genzyme sponsored program, has been established in order to better understand the variability and progression of Fabry disease in the population as a whole and in women, and to monitor and evaluate the long-term effects of Fabrazyme® (agalsidase beta). The Registry will also monitor the effect of Fabrazyme on pregnant women and their offspring, and determine if Fabrazyme is excreted in breast milk. Patients should be encouraged to participate and advised that their participation is voluntary and may involve long-term follow-up. For more information visit www.fabryregistry.com or call (800) 745-4447, x15500.

Open Database

The Fabry Registry’s open database helps optimize patient outcomes and increase the understanding of Fabry disease by:

  • Providing individualized patient reports and informative clinical summaries to submitting physicians
  • Encouraging physician collaboration and shared expertise
  • Facilitating publications

Physicians may publish analyses on aggregate Registry data.

Independent Board of Advisors

The Fabry Registry is guided by an independent group of physicians with extensive experience in managing patients with Fabry disease.

Registry Integrity

The Fabry Registry maintains its integrity by a commitment to patient privacy and confidentiality, as well as a commitment to the quality of the data. To promote comprehensive data collection, the Fabry Registry is open to all patients with Fabry disease, regardless of treatment modality.

Confidentiality Assurance

Patient - and physician-identifiable information submitted to the Fabry Registry is maintained as confidential in accordance with applicable national privacy regulations and other state and local laws related to medical information.

Dedicated Registry Team

The Fabry Registry team is comprised of experienced healthcare professionals committed to the highest standards of excellence and ethics.

How to get started

All physicians currently managing a patient with Fabry disease are eligible to enroll in the Fabry Registry. Get started by calling 617-591-5500 or 800-745-4447, ext. 15500, or visit the Fabry Registry online.


Keyword: 
Search In: 
Contact Information
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142
617 768 9000
800 745 4447
Contact Us
 
This website is intended for use in the United States. Please visit the Genzyme website for your country or region.



Terms and Conditions of Use | Privacy Policy | © 2003-2008 Genzyme Corporation. All rights reserved. |  Fabr/US/P133/02/07 |  Site Map
Genzyme Therapeutics